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Background and purpose   Hospital volume has been suggested 
to be one of the best indicators of adverse orthopedic events in 
patients undergoing THR surgery. We therefore evaluated the 
effect of hospital volume on the length of stay, re-admissions, and 
complications of THR at the population level in Finland.
Methods   30,266 THRs performed for primary osteoarthritis 
were identified from the Hospital Discharge Register. Hospitals 
were classified into 4 groups according to the number of THRs 
performed on an annual basis over the whole study period: 1–50 
(group 1), 51–150 (group 2), 151–300 (group 3), and > 300 (group 
4). 
Results   In 2005, the length of the period of surgical treatment 
was 5.5 days in group 4 and 6.8 days in group 1 (the reference 
group). During the whole study period (1998–2005), the length of 
surgical treatment period was shorter in group 4 than in group 1 
(p < 0.001). The odds ratio for dislocations (0.7, 95% CI: 0.6–0.9) 
was lower in group 3 than in group 1.
Interpretation   Hip replacements performed in high-volume 
hospitals reduce costs by shortening the length of stay, and they 
may reduce the dislocation rate.
 
The association between hospital volume and results of total 
hip replacement (THR) has been investigated in several stud-
ies (Lavernia and Guzman 1995, Battaglia et al. 2006, Doro 
et al. 2006, Shervin et al. 2007). The surgeon volume and the 
hospital volume have been suggested to be the best indicators 
of adverse orthopedic events in patients undergoing THR sur-
gery (Solomon et al. 2002). A systematic review of the litera-
ture found an association between high hospital volumes and 
low numbers of hip dislocations (Shervin et al. 2007). Lower 
provider volumes have been related to longer hospital stay 
after THR surgery (Lavernia and Guzman 1995, Doro et al. 
2006, Judge et al. 2006).
We evaluated the effects of hospital volume on the length of 
stay, the number of re-admissions, and the number of compli-
cations of THRs in the whole population of Finland.
Patients and methods
All public and private hospitals in Finland are obliged to 
report any surgical procedures requiring an overnight stay to 
the National Institute for Health and Welfare. The Hospital 
Discharge Register, which is maintained by the National Insti-
tute for Health and Welfare, was the main database we used. 
All other data were obtained from the following sources: the 
Benchmarking database compiled for the Hospital Bench-
marking project for productivity in specialized care (Linna 
and Häkkinen 2008), the Social Insurance Institution data-
base, and the Finnish Arthroplasty Register. The characteris-
tics of the data derived from these registries are dealt with 
later. Every Finnish resident has a unique personal identifica-
tion number, which can be used to combine data from differ-
ent registers. 
The effect of hospital volume on the length of the surgical 
treatment period (referred to later as length of stay (LOS)), the 
length of uninterrupted institutional care (LUIC), and the rates 
of unscheduled re-admissions, reoperations, dislocations, and 
infections were evaluated. The surgical treatment period was 
defined as the period during which the THR was performed 
in the hospital, as shown by the Hospital Discharge Register. 
A surgical treatment period ended in discharge, in transfer to 
another facility, or in death of the patient. Uninterrupted insti-
tutional care was defined as the combination of the surgical 
treatment period and the immediate period of rehabilitation. 
Uninterrupted institutional care ended in either death or dis-
charge of the patient, which also included the patient being 
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another long-term care or social welfare institution. The maxi-
mum length of institutional care was limited to 60 days as a 
cutoff point in the calculations. The study period was from 
1998 through 2005. Reoperations, closed and open reductions 
of dislocated hip prostheses, and infections of the THR were 
followed to the end of 2008.
Hospital grouping
Hospitals were classified into 4 groups according to the 
number of THRs (NOMESCO codes NFB30–NFB99) per-
formed annually during the whole study period: 1–50 (low-
volume hospitals, group 1), 51–150 (medium-volume hospi-
tals, group 2), 151–300 (high-volume hospitals, group 3), and 
> 300 (very-high-volume hospitals, group 4) (Table 1). The 
low-volume hospitals were used as a reference group.
There were 72 hospitals involved. Hospitals that changed 
hospital volume group during the study period were also 
included. 39 hospitals did not change volume group (9,926 
hips) and 33 hospitals changed volume group once (20,340 
hips). None of the hospitals changed volume group more than 
once.
Inclusion criteria
The study population was formed by selecting patients from 
the Hospital Discharge Register according to the Interna-
tional Classification of Diseases (ICD-10), and the follow-
ing were used as selection criteria: M16.0/M16.1 for primary 
osteoarthritis (OA) of the hip or M16.2/M16.3 for develop-
mental dysplasia of the hip (DDH), associated with a code for 
primary THA performed over the 1998–2005 period. Patients 
with a diagnosis of developmental dysplasia of the hip (DDH) 
(ICD-10: M16.2/M16.3) were included in the study because 
there is variation in coding of mild DDH and primary OA. 
Codes for THR included NFB30 for cementless THR, NFB40 
for hybrid THR, NFB50 for cemented THR, NFB60 for 
demanding THR, and NFB99 for other THR procedures such 
as hip resurfacing. Patients with congenital hip dislocation are 
classified under a different diagnosis code (Q65.0-Q65.9) and 
were not included in the study. The accuracy of diagnosis for 
primary OA was double-checked against the relevant data in 
the Finnish Arthroplasty Register. Total hip replacements—
not patients—were evaluated when considering the length of 
surgical treatment period, the length of institutional care, and 
unscheduled re-admissions. Thus, it was possible that 2 THRs 
were evaluated from the same patient. The total number of 
all the THRs included was 30,266. However, when consid-
ering reoperations, dislocations, and infections, only patients 
with unilateral THR implants were evaluated over the period 
1988–2008 (n = 20,814) (Table 2). The reason for this is that 
the side of the operation (left/right) is not reliably coded in 
the Hospital Discharge Register. If the data for the side of the 
operation are unavailable, then it is not possible to compare 
left-side with right-side THR from the registry data with any 
certainty. 
Exclusion criteria
THRs for secondary OA, reoperations, and revisions of an 
implant were excluded (Table 3, see supplementary data). 
The manifestation of the diagnosis of secondary hip OA was 
noted retrospectively from the beginning of 1988. A patient 
was excluded from the study if there was a diagnosis of sec-
ondary hip OA in the Hospital Discharge Register between 
the beginning of 1988 and the day of the operation. Patients 
Table 1. Number of patients and annual number of hospitals in different hospital volume groups, with annual 
number of private hospitals in parentheses 
Group  No. of  Annual no. of hospitals
 patients
  1998–2005  1998 1999 2000 2001 2002 2003 2004 2005
1  2,759  15 (7)  18 (8)  23 (8)  25 (9)  23 (10)  19 (11)  19 (10)  18 (9)
2  11,591  29 (2)  32 (2)  26 (2)  26 (3)  28 (2)  22 (2)  21 (2)  23 (4)
3  8,134    2 (0)    9 (0)    9 (0)    8 (0)  10 (1)    9 (0)  10 (0)    8 (0)
4  7,782    1 (1)    2 (1)    4 (1)    5 (1)    3 (1)    7 (2)    6 (2)    9 (2)
Total  30,266  57 (10)  61 (11)  62 (11)  64 (13)  64 (14)  57 (15)  56 (14)  58 (15)
See Material and Methods for explanation of groups
Table 2. Number (Na) and percentage of replace-
ments in cohorts when analyzing length of stay and 
unscheduled re-admissions, and number (Nb) and 
percentage of replacements in cohorts when analyz-
ing dislocations, re-operations, and infections
Cohort  No. (Na) of hips (%)  No. (Nb) of hips (%)
1998    2,863 (10)    1,906 (9)
1999    3,083 (10)    2,025 (10)
2000    3,360 (11)    2,178 (11)
2001    3,554 (12)    2,389 (12)
2002    3,877 (13)    2,639 (13)
2003    4,336 (14)    3,056 (15)
2004    4,113 (14)    2,963 (14)
2005    5,080 (17)    3,658 (18)
Total  30,266 (100)  20,814 (100)22  Acta Orthopaedica 2010; 82 (1): 20–26
who were eligible for reimbursement in the Social Insurance 
Institution database for the sequelae of transplantation, uremia 
requiring dialysis, rheumatoid arthritis, or connective tissue 
disease were also excluded from the study. Patients with a 
simultaneously performed hip and knee arthroplasty were also 
excluded.
Dislocations
We defined a reduction of a dislocated THR in 2 ways. Firstly, 
a reduction of a dislocated THR was considered to have been 
performed if there was a notification in the Hospital Discharge 
Register that either an open or closed reduction of a dislocated 
total hip prosthesis had been performed (NFH30 or NFH32), 
associated with a diagnosis of an internal mechanical com-
plication of endoprosthesis (ICD10: T84.0). Secondly, closed 
reduction may also have been performed in the emergency 
room under light sedation anesthesia. These patients are often 
discharged from the accident and emergency units after closed 
reduction without an overnight stay in the hospital. Accord-
ing to Finnish regulations, it is mandatory to compile statistics 
on diagnosis codes in the accident and emergency units but 
relevant operational codes are not recorded routinely. Thus, a 
closed reduction of a dislocated THR was considered to have 
been performed if the patient had an unscheduled re-admis-
sion with a diagnosis code of mechanical complication of 
endoprosthesis (ICD: T84.0) but without any actual hospital 
admission. We believe that most of these non-admission cases 
are true dislocations, not periprosthetic fractures or aseptic 
loosening of the implant. 
Infections
A diagnosis code for deep prosthetic infection (ICD-10: T84.5) 
was used in the data search from the beginning of the surgical 
treatment period to the end of the follow-up. Data from the 
Finnish Arthroplasty Register were used to determine reopera-
tions performed due to deep prosthetic infections. 
Unscheduled re-admission
An unscheduled re-admission was recorded if a patient was 
re-admitted to hospital or had required medical attention in 
an outpatient department or an accident and emergency unit 
of any hospital in Finland. Such an unscheduled re-admission 
also had to occur within the first 14 and the first 42 days from 
the end of the surgical treatment. 
Costs 
The total cost of 1 day of treatment in a specialized care facil-
ity was used to calculate the potential savings if all THRs had 
been performed in the group of hospitals with the shortest 
LOS. The price of 1 day of treatment in hospitals perform-
ing THRs was on average 527 euros in Helsinki and Uusimaa 
district (HUS) during the period 2003–2005 (Peltola 2008). 
However, the mean cost of 1 day of treatment in hospitals per-
forming THRs was not available for the whole country. The 
price of 1 re-admission in a specialized care facility was used 
to calculate increase in the costs if all THRs had been per-
formed in the group of hospitals with the highest amount of 
re-admissions at 2 weeks. In 2006, the price of 1 re-admission 
in a specialized care facility was 278 euros on average in the 
whole country (Hujanen et al. 2008).
Statistics
A logistic regression model for data at the individual level was 
used for dichotomous dependent variables and a generalized 
linear model (gamma-distribution, log-link) was used for con-
tinuous dependent variables, with hospital volume (classified) 
as explanatory variable. To improve the comparability of the 
study data, the analyses were adjusted for confounding factors 
(Iezzoni 2003). In addition, 95% confidence intervals (CIs) 
were determined. The age of the patient (under 40 years, over 
40 years (divided into 9 incremental groups each of 5-year 
intervals up to 85 years), and over 85 years), sex, any previous 
THR, and co-morbidities were also adjusted for. In the models 
of LOS and LUIC, operation year dummies were included. We 
also performed calculations using head size of the prostheses 
as an adjustment factor to eliminate the effect of head size 
on dislocation rate. Co-morbidities were determined using 
the diagnoses obtained from the Hospital Discharge Register 
from the beginning of 1987 to the date of operation. In addi-
tion, the Social Insurance Institution database for eligibility 
for reimbursement including the use and cost of drugs was 
used to adjust for co-morbidity (Table 4). The illnesses chosen 
for adjustment were such that they might have had an effect on 
the performance of THR, on length of stay in the hospital, or 
on the rate of complications. The length of follow-up was also 
identified as a confounding factor for adjustment of the rates 
of complications.
Results
Length of stay (LOS) and length of uninterrupted 
institutional care (LUIC) (Table 5) 
In 2005, LOS was 5.49 days in group 4, 6.65 days in group 
3, 7.63 days in group 2, and 6.84 days in group 1 (the refer-
ence group). During the whole study period, LOS was longer 
in group 1 than in group 4 (p < 0.001). However, LOS was 
shorter in group 1 than in group 2 (p < 0.001). In 2005, LUIC 
was 9.91 days in group 4, 10.47 days in group 3, 10.59 days 
in group 2, and 10.27 days in group 1. During the whole study 
period, LUIC was shorter in group 4 than in group 1 (p < 
0.001). Nonetheless, LUIC was longer in group 3 and in group 
2 than in group 1 (p < 0.001 for both comparisons). 
Theoretically, if all THRs during the study period in Finland 
had been performed in the very–high-volume hospitals with 
the shortest length of stay, total LOS in the hospital would 
have decreased by 29,761 days (1.0 day per patient). Thus, the 
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If all THRs during the study period in Finland had been per-
formed in the very–high-volume hospitals, this would have led 
to a total of 355 new re-admissions at 2 weeks. The increase 
in cost for these re-admissions would have been 98,690 euros. 
If we then subtract the increased costs due to a higher rate 
of re-admissions (98,690 euros) from the total savings in LOS 
(15,684,047 euros), the final savings during the follow-up 
time would have been 15,585,357 euros.
Complications (Table 6)
In unadjusted data, statistically there were significantly less 
dislocations in groups 3 and 4 than in group 1. There were also 
less reoperations in group 4 than in group 1. In group 1, there 
were more re-admissions both at 2 and 6 weeks than in group 
1. However, in adjusted data there was only a trend of fewer 
re-admissions within 14 days in group 1 than in group 4. There 
were significantly more dislocations in group 1 than in group 
3. There was no association between hospital volume and 
reoperation rates or infection rates when using adjusted data.
We also performed the analyses using the ownership of the 
hospitals (private or public) as a confounding factor. Of all 
30, 266 hips studied, 4,150 hips were operated on in private 
hospitals. There was no significant difference between hos-
pital volume results when the private/public dichotomy was 
included in the model. LOS was statistically significantly 
shorter in private hospitals than in public hospitals.
Table 4. Related diseases used in the adjustment of the study popu-
lation
Hypertension (ICD-10: I10*-I15*, ICD-9: 40*, Social Insurance 
Institutions entitlement to reimbursement: 205, use and cost 
of drugs ATC: C03*, C07* (if there is no coronary disease or 
atrial fibrillation), C09A*, C09B*, C09C*, C09D*, C08*)
Coronary disease (ICD-10: I20*-I25*, ICD-9: 410*-414*, Social Insur-
ance Institutions entitlement to reimbursement: 206, 213, 
280)
Atrial fibrillation (ICD-10: I48*, ICD-9: 4273*, Social Insurance Institu-
tions entitlement to reimbursement: 207, use and cost of 
drugs ATC: B01AA03)
Heart insufficiency (ICD-10: I50*, ICD-9: 428*, Social Insurance 
Institutions entitlement to reimbursement: 201)
Diabetes (ICD-10: E10*-E14*, ICD-9: 250*, Social Insurance Institu-
tions entitlement to reimbursement: 103 use and cost of 
drugs ATC-DDD: A10A*, A10B*)
Cancer (ICD-10: C00*-C99*, D00*-D09*, ICD-9: 140*-208*, Social 
Insurance Institutions entitlement to reimbursement: 115, 
116, 117, 128, 130, 180, 184, 185, 189, 311, 312, 316, use 
and cost of drugs ATC L01* except L01BA01)
COPD and asthma (ICD-10: J44*-J46*, ICD-9: 4912*, 496*, 493*, 
Social Insurance Institutions entitlement to reimbursement: 
203, use and cost of drugs ATC: R03*)
Depression (ICD-10: F32*-F34*, ICD-9: 2960*, 2961*, 2069*, use 
and cost of drugs ATC: N06A*)
Parkinson’s disease (ICD-10: G20*, ICD-9: 332*, Social Insurance 
Institutions entitlement to reimbursement: 110, use and cost 
of drugs ATC: N04B*)
Dementia (ICD-10: F00*-F03*, G30*, ICD-9: 290*, 3310*, Social 
Insurance Institutions entitlement to reimbursement: 307, 
use and cost of drugs ATC: N06D*)
Kidney insufficiency (ICD-10: N18*, ICD-9: 585*, Social Insurance 
Institutions entitlement to reimbursement: 137)
Mental disorders (ICD-10: F20*-F31*, ICD-9: 295*-298*, except 
2960*, 2961*, Social Insurance Institutions entitlement to 
reimbursement: N05A* except N05AB04 and N05AB01 and 
there is no dementia)
Table 5. The average length of stay and the number of days saved 
if patients were treated in hospitals with the shortest length of stay
       Difference
Year  Group  LOS  N  in LOS  Days saved
1998 1  10.06  233  0.35 82
  2  10.52 1,395  0.81  1,130 
  3  9.05 1,145 -0.66  -756 
 4    9.71 90  – – 
  In total    2,863   456 
1999 1  9.80  227 0.59  134
 2  10.01 1,664  0.8  1,331 
 3  8.85  953 -0.36  -343 
 4  9.21 239  –  – 
  In total    3,083    1,122
2000 1  9.37  388 1.50  582 
 2  9.81 1,452  1.94  2,817 
 3  8.82  932 0.95  885 
 4  7.87 588  –  – 
  In total    3,360    4,284
2001 1  8.65  493 0.92  454
 2  9.66 1,386  1.93  2,675
 3  8.57  899 0.84  755
 4  7.73 776  –  –
  In total    3,554    3,884
2002  1  8.34  449 1.21  543
  2  9.15 1,647  2.02  3,327 
  3  7.76 1,207  0.63  760 
  4   7.13 574  –  – 
  In total    3,877   4,630 
2003  1  7.17  315 1.08  340 
  2  8.58 1,358  2.49  3,381 
  3  7.93  988 1.84 1,818 
 4    6.09 1,675  –  – 
  In total    4,336    5,539
2004  1  7.22  346 1.34  464 
  2  8.46 1,181  2.58  3047
  3  7.38 1,059  1.50  1,589 
 4    5.88 1,527  –  – 
  In total    4,113    5,100 
2005  1  6.84  308 1.35  416
  2  7.63 1,508  2.14  3,227
  3  6.65  951 1.16 1,103
 4    5.49 2,313  –  – 
  In total    5,080    4,746 
1998–2005       29,761
LOS: annual mean length of stay (surgical treatment period) in days; 
N: number of patients; Difference in LOS: difference between the 
shortest length of stay and that of other hospital groups in days; 
Days saved: number of days saved if patients were operated in 
hospitals with the shortest length of stay (days saved = difference 
in LOS multiplied by N). In 1998 and 1999, the average LOS was 
shorter in group 3 than in group 4. This is why “Difference in LOS” 
and “Days saved” have negative values in the Table.24  Acta Orthopaedica 2010; 82 (1): 20–26
Discussion
Our findings indicate that specialization of hip replacements 
in high-volume hospitals should reduce costs by shortening 
LOS, and may reduce the dislocation rate.
Validity of the data
The reporting accuracy of the Hospital Discharge Register 
in Finland is high when considering surgical operations. In 
the late 1980s, at least 95% of operations were already being 
recorded in this register (Keskimäki and Aro 1991). The cor-
relation between the Finnish Discharge Register and the Finn-
ish Arthroplasty Register is high (Peltola 2008). The strength 
of our study is that it included operative data from both pri-
vate and public hospitals. We adjusted for patient age, sex, 
surgery, and medical diagnosis. Adjustment calculations were 
also done for the head size of the prosthesis. However, not 
all factors associated with dislocation rate, such as surgical 
approach, could be adjusted for in the data from the current 
study.
Our basic assumption was that performing more hip surgery 
correlates with skills. Change of hospital volume group would 
not interfere with our analyses if hospital volume is an impor-
tant factor compared to other variables affecting the quality of 
hip surgery. 
Length of stay
The LOS after THR varies considerably. There are reports 
in the literature that THRs have actually been performed as 
day-case surgery (Berger et al. 2004), even though very early 
discharge has been cautioned against (Parvizi et al. 2007). 
Nevertheless, reducing LOS reduces the cost of care and per-
mits increase in bed occupancy rates (Williams et al. 2005). 
In previous studies, longer LOSs after THR have been asso-
ciated with lower provider volumes (Lavernia and Guzman 
1995, Doro et al. 2006, Judge et. al. 2006). In our study, not 
only was a very high hospital volume associated with shorter 
surgical treatment periods but also with shorter LUIC. Large 
amounts of money can be saved if THRs are performed in 
very–high-volume hospitals. However, when the postopera-
tive care is made more efficient, the easiest and cheapest days 
are removed, not the heaviest days including the first post-
operative day and the discharge day. In the near future in 
Finland, a large number of people born in the late 1940s and 
early 1950s will retire. Because of the aging population and 
the decreasing number of nurses, more patients will have to 
be treated using the same resources as those used today—by 
optimizing efficiency.
 
Unscheduled re-admissions 
Unscheduled re-admission rate is a national key performance 
indicator used by the UK Department of Health (Adeyemo 
and Radley 2007). A 28-day emergency re-admission rate has 
been used as a clinical indicator to compare surgical and ortho-
pedic performance between trusts in England and in Scotland 
(Courtney et al. 2003). In a study by Cullen et al. (2006), 9% 
Table 6a. Unadjusted odds ratios for unscheduled re-admissions within 14 and 42 days, and for dislocations, reoperations, and 
infections 
  Re-admsissions Re-admsissions  Dislocations  Reoperations Infections
  14 days  42 days     
Groups  OR  95% WCI  OR  95% WCI  OR  95% WCI  OR  95% WCI  OR  95% WCI
2  vs.  1  0.9 0.8–1.1  0.9 0.8–1.0  0.9 0.7–1.2  1.1 0.9–1.3  1.0 0.7–1.6
3  vs.  1  1.0 0.9–1.2  1.0 0.8–1.1  0.7 0.6–0.9  1.0 0.8–1.2  0.9 0.6–1.5
4  vs.  1  1.2 1.0–1.4  1.1 1.0–1.3  0.8 0.6–1.0  0.7 0.5–0.9  0.8 0.5–1.3
OR: odds ratio; 95% WCI: 95% Wald confidence interval.
See Methods for explanation of groups.
Table 6b. Adjusted odds ratios for unscheduled re-admissions within 14 and 42 days, and for dislocations, reoperations, and 
infections
  Re-admsissions Re-admsissions  Dislocations  Reoperations Infections
  14 days  42 days     
Groups  OR  95% WCI  OR  95% WCI  OR  95% WCI  OR  95% WCI  OR  95% WCI
2  vs.  1  0.9 0.8–1.1  0.9 0.8–1.0  0.9 0.7–1.1  1.0 0.8–1.3  1.0 0.6–1.6
3  vs.  1  1.0 0.9–1.2  0.9 0.8–1.1  0.7 0.6–0.9  0.9 0.8–1.2  0.9 0.6–1.4
4  vs.  1  1.2 1.0–1.4  1.1 1.0–1.2  1.1 0.9–1.4  0.9 0.7–1.1  0.8 0.5–1.4
OR: odds ratio; 95% WCI: 95% Wald confidence interval.
See Methods for explanation of groups.Acta Orthopaedica 2010; 82 (1): 20–26  25
of patients were re-admitted within 28 days of discharge after 
THR. The main reasons for re-admission were thromboem-
bolism, dislocations, and wound complications. Reducing the 
length of stay lowered the cost of care per patient and per-
mitted increased bed occupancy, but the effect on emergency 
re-admission rates was equivocal (Williams et al. 2005). The 
odds ratio of emergency re-admission for primary hip replace-
ment was 0.54 when the length of stay was 4–7 days and 0.55 
when it was 8–14 days, considering the odds ratio 1.0, when 
the length of stay was 4 days or under (Williams et al. 2005). In 
a study by Judge et al. (2006), there was evidence of a higher 
re-admission rate for high-volume trusts. In our study, the rate 
of re-admissions in the low-volume hospitals was also lower 
than in all other hospital groups. When the length of stay is 
longer, early problems manifest in the hospital and are treated 
immediately in situ; thus, re-admissions are less likely to 
occur than in shorter-stay facilities. However, the reasons for 
re-admissions are most often not major surgical complications 
but minor wound problems, suspicion of venous thromboem-
bolism, and medication problems. The costs of re-admissions 
were low compared to the costs of longer length of stay.
Dislocations
The dislocation rate during the first year after THR has been 
reported to range from less than 1% to almost 4% (Phillips et 
al. 2003, Khatod et al. 2006, Meek et al. 2006). Several fac-
tors are constantly reported to be statistically associated with 
THR dislocation rate. These include surgical diagnosis, femo-
ral head size, patient age and sex, American Association of 
Anesthesiologists (ASA) score, cognitive dysfunction, surgi-
cal approach, surgeon volume, and hospital volume (Meek et 
al. 2006). It is not possible to influence all of these factors to 
reduce the number of dislocations. However, healthcare work-
ers should try to manipulate those factors that can be influ-
enced, such as surgeon volume, hospital volume, head size, 
and repair of soft tissues. 
In our study, the low-volume hospitals had higher disloca-
tion rates than the high-volume hospitals and the very–high-
volume hospitals. However, the dislocation rate for very-high-
volume hospitals was not lower than that of low-volume hospi-
tals when we analyzed adjusted data. The patients in large-vol-
ume units are probably somewhat younger than in low-volume 
hospitals. In small units, there are more typical osteoarthritic 
patients of advanced age who are at risk of having short-term 
complications. On the other hand, very–high-volume hospi-
tals are mainly university hospitals with junior surgeons who 
perform replacements as part of their education. Furthermore, 
not all diseases— for example, obesity and alcoholism—nor 
the condition of bone and soft tissues can be adjusted, and it 
is likely that even after adjustment, there will be more diffi-
cult patients in university hospitals that have adverse influen-
tial effects on the dislocation rates observed. High dislocation 
rates in low-volume hospitals are an alarming finding that has 
also been reported previously (Shervin et al. 2007).
Reoperations
Instability has been the most common reason for early reoper-
ations, whereas osteolysis and loosening are the most common 
reasons for late revisions (Clohisy et al. 2004). Because the 
follow-up time in our study was short, we assumed that many 
reoperations were performed either because of infections, 
instability, or periprosthetic fractures. Early dislocations after 
THR are most often treated by closed reduction; these were 
analyzed separately. Open reduction and revision operations 
as a treatment for dislocated hip prostheses are uncommon. 
Unfortunately, the reason for revision is not directly available 
from the Finnish Arthroplasty Register, only the type of revi-
sion performed (for example exchange of the stem with the 
diagnosis code NFC20, but not if the revision was performed 
for periprosthetic fracture or for dislocation, both of which 
have the diagnosis code T84.0). We found less reoperations 
in the very-high-volume group than in the low-volume group 
when using unadjusted raw data. However, this difference 
did not reach statistical significance when using the adjusted 
data. In a study by Manley et al. (2008), the patients of low-
volume surgeons had a greater risk of arthroplasty revision at 
6 months but no greater risk of revision at the time of longer-
term follow-up. No associations between hospital volumes 
and the rates of revision of THA were found by Judge et al. 
(2006) and Manley et al. (2008). 
Infections
In recent studies, the rate of deep infection after THA has 
varied between 0.6% and 0.9% (Gastmeier et al. 2005, Muil-
wijk et al. 2006, Phillips et al. 2006). Independent risk factors 
for surgical site infections after THR are patient age, surgical 
diagnosis, ASA score, and duration of operation (Ridgeway 
et al. 2005). In a systematic literature review, no associa-
tion between hospital volumes and infection rates was found 
(Shervin et al. 2007). Nowadays, deep infections after THR 
are rare that the capability of population-based studies to 
determine significant differences between hospitals is limited. 
In our study, patient age, sex, surgical diagnosis, and medical 
diagnoses were adjusted for. Thus, it was not surprising that 
no association between infection rate and hospital volume was 
detected.
Summary 
We found that LOS was shortest in the very-high-volume hos-
pitals. The costs of more frequent re-admissions in the very–
high-volume hospitals were low compared to the savings from 
short LOS. Specialization of high-volume hospitals regarding 
hip replacements should reduce costs by significantly shorten-
ing length of stay, and it may reduce the dislocation rate.
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